Technology | May 29, 2013

Breast tomosynthesis solution may offer more accurate method for breast cancer screening.

Hologic Receives FDA Approval for Low-Dose 3-D Mammography

May 29, 2013 — Hologic Inc. announced that the U.S. Food and Drug Administration (FDA) approved the use of Hologic's new C-View 2-D imaging software. C-View 2-D images may now be used in place of the conventional 2-D exposure previously required as part of a Hologic 3-D breast tomosynthesis screening exam.

C-View images are generated from the 3-D tomosynthesis data acquired during the mammography exam, eliminating the need for additional 2-D exposures. The combination of Hologic's 3-D and C-View 2-D images results in less time under compression, for greater patient comfort and a lower radiation dose, while still providing the 2-D images required as part of Hologic's FDA-approved 3-D mammography screening exam.

“Large-scale clinical studies have shown that screening with Hologic's 3-D mammography technology allows radiologists to visualize the breast in greater detail than with 2-D mammography alone, which results in earlier detection of cancers while at the same time reducing the false positives associated with conventional 2D mammography that cause unnecessary anxiety and cost,” said Peter Soltani, Hologic senior vice president and general manager, breast health.

Hologic's 3-D mammography technology has been approved for use in countries recognizing the CE mark since 2008. It was approved for use in the United States for breast cancer screening and diagnosis in 2011. Hologic systems are now in use in 48 states and over 50 countries.

For more information: www.breasttomo.com


Related Content

News | Breast Imaging

June 25, 2025 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time June 25, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Mammography

Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...

Time December 05, 2024
arrow
News | Mammography

Nov. 26, 2024 — GE HealthCare has introduced the Pristina Via* mammography system designed to enhance the screening ...

Time December 02, 2024
arrow
Subscribe Now